biomarkers

What if your prostate biopsy is missing the most important detail? In this powerful episode, Dr. Geo sits down with Dr. Jonathan Epstein, one of the most influential urologic pathologists in the world, to break down what’s really happening behind your diagnosis. From Gleason scores to hidden...

LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Explain the principles of molecular imaging and its application in prostate cancer, including techniques such as PET, MRI, and novel radiotracers. 2. Evaluate recent advances in molecular imaging...

In this video, Dr. Soania Mathur interviews Dr. Michael Okun about emerging therapies for Parkinson’s, including continuous infusion levodopa, cell replacement research, repurposed diabetes medication, and more! Chapters: 0:00 - Introduction 2:27 - Advances in Carbidopa and Levodopa 9:48 -...

Abstract Objective: The hypothalamic‐pituitary‐testicular axis is characterized by the existence of major functional changes from its establishment in fetal life until the end of puberty. The assessment of serum testosterone and gonadotrophins and semen analysis, typically used in the adult...

https://www.newswise.com/articles/desai-sethi-urology-institute-researcher-finds-sneaky-testosterone-might-signal-worse-outcomes-for-men-with-prostate-cancer...

Andrea Pilotto, MD, University of Brescia, Brescia, Italy, explains the major ongoing research regarding digital and fluid biomarkers for use in Parkinson’s disease (PD) diagnosis, monitoring, and prognostication. There is a huge interest in seed amplification assays (RT-QuIC) that detect...

How to ensure accurate results from a prostate biopsy? Suppose you've ever undergone a prostate biopsy. In that case, you may have wondered if the results are accurate, especially when the biopsy only retrieves minimal tissue from a large prostate. In this episode, we have invited Dr. Geo, an...

A major focus among those working in aging research and the preemption of chronic diseases is the identification of biomarkers. The field is intensively searching for biomarkers, surrogate markers, and registrable endpoints that can lead to the approval of therapeutic interventions without...

Abstract Purpose: Detecting prostate cancer, developing therapeutic plans after negative biopsies, and prognosis-based patient counseling can be challenging for many urologists dealing with prostate cancer-specific antigens. New Biomarkers advances made improvements for the prediction of...

Abstract from AUA2016.org Low Serum Testosterone is Associated with Elevations in High-Sensitivity Cardiovascular Disease Biomarkers Authors: Alexander W. Pastuszak*, Mark C. Lindgren, Samuel J. Ohlander, Amin Herati, Houston, TX, Joel Estis, Alameda, CA, Larry I. Lipshultz, Houston, TX...